Keywords: vioquest, initiates, ph, i/iia, trial, vqd-001, usa

VioQuest initiates Ph I/IIa trial of VQD-001

Article | 02 October 2006

Print This

The USA's VioQuest Pharmaceuticals has dosed the first patient in a Phase I/IIa clinical trial of VQD-001 (sodium stibogluconate), ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in